CNTG Centogene
- 0.4889
- +0.0090+1.88%
Centogene News
Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
Shares of Wang & Lee Group, Inc. (NASDAQ:WLGS) rose sharply in today's pre-market trading after the company reported a year-over-year increase in FY23 financial results.Wang & Lee Group posted a FY23
Centogene N.V. Faces Nasdaq Compliance Challenge
Express News | Centogene Receives Non-Compliance Notification Letter Dated March 27, 2024, From Nasdaq
CENTOGENE Receives Nasdaq Non-Compliance Notice
Centogene N.V. (NASDAQ:CNTG) ("Centogene", "we", or the "Company"), the essential life science partner for data-driven answers in rare and neurodegenerative diseases
Reproductive Genetics Market Analysis Report 2024-2032, Featuring Bangkok Genomics Innovation, Centogene, Fulgent Genetics, Igenomix, Invitae, PerkinElmer and Thermo Fisher Scientific
Centogene, Takeda Pharmaceutical Collaborate on Lysosomal Storage Disorders Diagnostics
Centogene (CNTG) said Tuesday it will continue to give Takeda Pharmaceutical (TAK) access to diagnostic testing for patients with Lysosomal Storage Disorders, or LSDs, under the companies' extended ag
Centogene, Takeda Extend Diagnostic Partnership
CENTOGENE and Takeda Boost Genetic Testing for LSDs
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders, Financial Terms Undisclosed
Centogene N.V. (NASDAQ:CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced the extension of an ongoing partnership with Takeda (NY
CENTOGENE Collaborates On Research Published In Science Showing Immunopathological Landscape Of Human Pre-TCRα Deficiency
CENTOGENE N.V. (NASDAQ:CNTG) (the "Company"), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced the publication in Science of research
Centogene Explores Strategic Alternatives, Incl. Sale
Centogene Reveals Receipt Of Nasdaq Notice Of Delisting And Intention To Request A Hearing
Centogene Reveals Receipt Of Nasdaq Notice Of Delisting And Intention To Request A Hearing
Centogene Says It Is Exploring A Range Of Strategic Alternatives Focused On Sustainable Long-term Value Creation For The Benefit Of Its Stakeholders
The company received a staff determination letter (the "Letter") on Feb. 27, 2024, from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company of the det
Centogene N.V.'s (NASDAQ:CNTG) Stock Retreats 27% But Revenues Haven't Escaped The Attention Of Investors
The Centogene N.V. (NASDAQ:CNTG) share price has fared very poorly over the last month, falling by a substantial 27%. The drop over the last 30 days has capped off a tough year for shareholders, wi
Centogene And The Laboratory Of Human Genetics Of Infectious Diseases At Institut Imagine Announced Rare Disease Research Collaboration; Specific Targets Of The Collaboration Were Not Disclosed
As part of the collaboration, CENTOGENE and the Lab will leverage the CENTOGENE Biodatabank, which contains over 70 million unique genetic variants collected from more than 800,000 patients from over
Centogene Has Been Recognized By French Ministry Of Higher Education And Research As Qualified Organization To Support Partners Conducting R&D Projects In France. It Has Received Accreditation Under The French R&D Tax Credit Initiative For Three Years-8K
Centogene Has Been Recognized By French Ministry Of Higher Education And Research As Qualified Organization To Support Partners Conducting R&D Projects In France. It Has Received Accreditation Under T
Centogene and MJFF Team up for Parkinson's Research
Express News | Centogene And Michael J. Fox Foundation For Parkinson's Research Announced Research Project On Genetic Risk Factors Associated With Parkinson's Disease, Specifically Targeting The Role Of Variants In GBA (Glucosylceramidase Beta) Gene
Buy Rating for Centogene NV Amidst Strategic Growth and Financial Partnerships
Centogene: Heading Into 2024, Our Pharma Orderbook Is Set to Hit New Record Levels >CNTG
Centogene: Heading Into 2024, Our Pharma Orderbook Is Set to Hit New Record Levels >CNTG
Analysis
Price Target
No Data
